15/04/2026
Strengthening Global Access to Quality Healthcare with 10 New Market Authorizations:
Venus Remedies continues to expand its reach with 10 new Market Authorizations across multiple international markets. These include Enoxaparin 20 mg/0.2 ml for El Salvador, Carboplatin Pontus 150 mg/15 ml and 450 mg/45 ml for Netherlands, Docetaxel Injection USP 80 mg/2 ml for Ethiopia, Meropenem 500 mg and Vincristine 1 mg/1 ml for Chile, Imipenem/Cilastatin 500 mg for Serbia, Vancomycin 1 gm for Iraq and Methotrexate Venus 1000 mg/10 ml for Saudi Arabia.
Additionally we take pride in Strategic Milestones, such as the registration of Carboplatin in Georgia and the first-time approval of Midazolam 15 mg/3 ml, further strengthen our presence in critical care and emerging market!
News Coverage by : Mr. Anmol Sharma, Mr. Chetan, Mr. Vikas and Ms. Maneesha Bhatt, Reporters at Venus pulse.
